Publications by Dr Anna Mayhew - ePrints

Browsing publications by Dr Anna Mayhew.

Newcastle Authors	Title	Year
Dr Anna Mayhew Robert Muni Lofra Professor Chiara Marini Bettolo	Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international study	2024
Dr Anna Mayhew Robert Muni Lofra Professor Chiara Marini Bettolo	Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3	2024
Dr Marianela Schiava Robert Muni Lofra Dr John Bourke Meredith James Professor Jordi Diaz Manera et al.	Disease-associated comorbidities, medication records and anthropometric measures in adults with Duchenne muscular dystrophy	2024
Dr Marianela Schiava Dr Anna Mayhew Professor Michela Guglieri	Factors Associated With Early Motor Function Trajectories in DMD After Glucocorticoid Initiation: Post Hoc Analysis of the FOR-DMD Trial	2024
Dr Marianela Schiava Dr John Bourke Meredith James Dr Maha Elseed Dr Monika Malinova et al.	Functional abilities, respiratory and cardiac function in a large cohort of adults with Duchenne muscular dystrophy treated with glucocorticoids	2024
Dr Ursula Moore Dr Anna Mayhew Heather Hilsden Dr Hai The Pham Meredith James et al.	Performance of upper limb entry item to predict forced vital capacity in dysferlin-deficient limb girdle muscular dystrophy	2024
Dr Marianela Schiava Dr Anna Mayhew Professor Michela Guglieri	Reference curves of motor function outcomes in young steroid-naïve males with Duchenne muscular dystrophy	2024
Meredith James Professor Michela Guglieri Dr Anna Mayhew	Understanding North Star Ambulatory Assessment total scores and their implications for standards of care using observational data	2024
Dr Anna Mayhew Robert Muni Lofra Professor Chiara Marini Bettolo	2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA Participants	2023
Dr Claire Wood Dr Kieren Hollingsworth Edrina Bokaie Dr Eric Hughes Robert Muni Lofra et al.	Is ongoing testosterone required after pubertal induction in Duchenne muscular dystrophy?	2023
Dr Ursula Moore Esther Fernández-Simón Dr Marianela Schiava Daniel Cox Meredith James et al.	Myostatin and follistatin as monitoring and prognostic biomarkers in dysferlinopathy	2023
Dr Anna Mayhew Dionne Moat Robert Muni Lofra Jassi Sodhi	Adult North Star Network (ANSN): Consensus Document for Therapists Working with Adults with Duchenne Muscular Dystrophy (DMD) - Therapy Guidelines	2022
Meredith James Dr Michelle Eagle Robert Muni Lofra Dr ursula Moore Professor Michela Guglieri et al.	Assessing Dysferlinopathy Patients Over Three Years With a New Motor Scale	2022
Dr Anna Mayhew Meredith James Dr ursula Moore Helen Sutherland Robert Muni Lofra et al.	Assessing the Relationship of Patient Reported Outcome Measures With Functional Status in Dysferlinopathy: A Rasch Analysis Approach	2022
Dr ursula Moore Roberto Fernandez-Torron Meredith James Dr Anna Mayhew Dr Lizzie Harris et al.	Cardiac and pulmonary findings in dysferlinopathy: A 3-year, longitudinal study	2022
Dr Marianela Schiava Dr Henriette van Ruiten Dr Anna Mayhew Emerita Professor Elaine McColl Dr Tracey Willis et al.	Clinical and Genetic Characteristics in Young, Glucocorticoid-Naive Boys With Duchenne Muscular Dystrophy.	2022
Meredith James Dr Anna Mayhew Emerita Professor Katherine Bushby Professor Volker Straub	Comparison of strength testing modalities in dysferlinopathy	2022
Dr Anna Mayhew Professor Michela Guglieri	Editorial: Lessons Learned from Translational Research in Neuromuscular Diseases: Impact on Study Design, Outcome Measures and Managing Expectation	2022
Dr Anna Mayhew Dionne Moat Dr Michelle Eagle Meredith James Robert Muni Lofra et al.	Functional outcome measures in young, steroid-naïve boys with Duchenne muscular dystrophy	2022
Professor Michela Guglieri Dr Anna Mayhew	Novel approaches to analysis of the North Star Ambulatory Assessment (NSAA) in Duchenne muscular dystrophy (DMD): Observations from a phase 2 trial	2022
Robert Muni Lofra Dr Lindsay Murphy Professor Chiara Marini Bettolo Dr Anna Mayhew	Real-World Data on Access to Standards of Care for People With Spinal Muscular Atrophy in the UK	2022
Dr Anna Mayhew Professor Volker Straub Professor Chiara Marini Bettolo	Revised Hammersmith Scale for spinal muscular atrophy: Inter and intra-rater reliability and agreement	2022
Dr Fiona Smith Dr Ian Wilson Roberto Fernandez-Torron Meredith James Dr Ursula Moore et al.	Three-year quantitative magnetic resonance imaging and phosphorus magnetic resonance spectroscopy study in lower limb muscle in dysferlinopathy	2022
Meredith James Robert Muni Lofra Dionne Moat Mark Richardson Dr Michelle Eagle et al.	Validation of the North Star Assessment for Limb-Girdle Type Muscular Dystrophies	2022
Dr ursula Moore Dr Fiona Smith Dr Ian Wilson Meredith James Dr Anna Mayhew et al.	Water T2 could predict functional decline in patients with dysferlinopathy	2022
Robert Muni Lofra Ruth Wake Dr Anna Mayhew Professor Chiara Marini Bettolo	Longitudinal changes in respiratory and upper limb function in a pediatric type III spinal muscular atrophy cohort after loss of ambulation	2021
Dr Ursula Moore Meredith James Dr Anna Mayhew Professor Michela Guglieri Roberto Fernandez-Torron et al.	Miyoshi myopathy and limb girdle muscular dystrophy R2 are the same disease	2021
Mark Richardson Dr Anna Mayhew Robert Muni Lofra Dr Lindsay Murphy Professor Volker Straub et al.	Prevalence of pain within limb girdle muscular dystrophy r9 and implications for other degenerative diseases	2021
Dr Claire Wood Dr Kieren Hollingsworth Dr Eric Hughes Dr Sadha Punniyakodi Robert Muni Lofra et al.	Pubertal induction in adolescents with DMD is associated with high satisfaction, gonadotropin release and increased muscle contractile surface area	2021
Dr Anna Mayhew Robert Muni Lofra Professor Chiara Marini Bettolo	Clinical Variability in Spinal Muscular Atrophy Type III	2020
Dr Ursula Moore Roberto Fernandez-Torron Meredith James Dr Anna Mayhew Professor Andrew Blamire et al.	Intensive Teenage Activity Is Associated With Greater Muscle Hyperintensity on T1W Magnetic Resonance Imaging in Adults With Dysferlinopathy	2020
Dr Anna Mayhew Roberto Fernandez-Torron Dr Michelle Eagle Karen Bettinson Professor Andrew Blamire et al.	Assessment of disease progression in dysferlinopathy – a 1 year cohort study	2019
Dr Anna Mayhew Professor Michela Guglieri	Categorising trajectories and individual item changes of the North Star Ambulatory Assessment in patients with Duchenne muscular dystrophy	2019
Dr Alex Murphy Meredith James Dr Anna Mayhew Dr Michelle Eagle Dr Kieren Hollingsworth et al.	Natural history of limb girdle musclar dystrophy R9 over 6 years: searching for trial endpoints	2019
Dr Claire Wood Professor Timothy Cheetham Dr Kieren Hollingsworth Professor Michela Guglieri Dr Anna Mayhew et al.	Observational study of clinical outcomes for testosterone treatment of pubertal delay in Duchenne muscular dystrophy	2019
Dr Anna Mayhew Meredith James Professor Volker Straub	Performance of Upper Limb module for Duchenne muscular dystrophy	2019
Dr Anna Mayhew Robert Muni Lofra Professor Volker Straub	Revised upper limb module for spinal muscular atrophy: 12 month changes	2019
Professor Jordi Diaz Manera Roberto Fernandez-Torron Meredith James Dr Anna Mayhew Dr Fiona Smith et al.	Muscle MRI in dysferlinopathy patients: Pattern recognition and implications for clinical trials	2018
Dr Anna Mayhew Robert Muni Lofra	Quantitative Evaluation of Lower Extremity Joint Contractures in Spinal Muscular Atrophy: Implications for Motor Function	2018
Dr Ursula Moore Roberto Fernandez-Torron Meredith James Dr Anna Mayhew Dr Michelle Eagle et al.	Teenage exercise is associated with earlier symptom onset in dysferlinopathy: a retrospective cohort study	2018
Dr Anna Mayhew	Development of a patient-reported outcome measure for upper limb function in Duchenne muscular dystrophy: DMD Upper Limb PROM	2017
Libby Wood Professor Chiara Marini Bettolo Professor Michela Guglieri Dr Grace McMacken Dr Anna Mayhew et al.	Respiratory involvement in ambulant and non-ambulant patients with facioscapulohumeral muscular dystrophy	2017
Dr Ursula Moore Meredith James Dr Anna Mayhew Dr Fiona Smith Dr Lizzie Harris et al.	Clinical outcome study for dysferlinopathy: One-year follow-up	2016
Dr Anna Mayhew Dr Michelle Eagle Professor Michela Guglieri Professor Volker Straub Professor Hanns Lochmuller et al.	Corrigendum to Development and psychometric analysis of the Duchenne muscular dystrophy Functional Ability Self-Assessment Tool (DMDSAT) (vol 25, pg 937, 2015)	2016
Dr Michelle Eagle Dr Anna Mayhew Professor Michela Guglieri Professor Volker Straub	Outcome measures for Duchenne muscular dystrophy from ambulant to non-ambulant: Implications for clinical trials	2016
David Rawlings Dr Claire Wood Professor Timothy Cheetham Dr Cecilia Jimenez Moreno Dr Anna Mayhew et al.	Prophylactic oral bisphosphonate therapy in duchenne muscular dystrophy	2016
Dr Anna Mayhew Emerita Professor Katherine Bushby	Revised Hammersmith scale for spinal muscular atrophy: Longitudinal changes over six and twelve months in a large international cohort	2016
Dr Lizzie Harris Dr Catherine Bladen Dr Anna Mayhew Meredith James Karen Bettinson et al.	The Clinical Outcome Study for dysferlinopathy: An international multicenter study	2016
Dr Anna Mayhew Dr Michelle Eagle Professor Michela Guglieri Professor Volker Straub Professor Hanns Lochmuller et al.	Development and Psychometric Analysis of the Duchenne Muscular Dystrophy Functional Ability Self-Assessment Tool (DMDSAT)	2015
Dr Cecilia Jimenez Moreno Dr Sira Moreno Dr Michelle Eagle Dr Anna Mayhew Meredith James et al.	Impact of three decades of improvement in standards of care for Duchenne muscular dystrophy	2015
Dr Stephen Lynn Professor Annemieke Aartsma-Rus Emerita Professor Katherine Bushby Dr Anna Mayhew Professor Volker Straub et al.	Measuring clinical effectiveness of medicinal products for the treatment of Duchenne muscular dystrophy	2015
Dr Anna Mayhew Meredith James Dr Michelle Eagle Dr Catherine Bladen Karen Bettinson et al.	Preparation of a disease specific functional measure suitable for trials in dysferlinopathy	2015
Dr Lizzie Harris Karen Bettinson Meredith James Dr Anna Mayhew Dr Michelle Eagle et al.	International Clinical Outcome Study in Dysferlinopathy (COS): Results of screening questionnaires in UK patients	2014
Dr Tracey Willis Dr Kieren Hollingsworth Dr Michelle Eagle Dr Anna Mayhew Emerita Professor Katherine Bushby et al.	Quantitative Magnetic Resonance Imaging in Limb-Girdle Muscular Dystrophy 2I: A Multinational Cross-Sectional Study	2014
Dr Michelle Eagle Dr Anna Mayhew Karen Bettinson Meredith James Dr Brigitta von Rekowski et al.	Clinical outcome measures for dysferlinopathy: An exploration of reliability and suitability of novel functional rating scales	2013
Dr Anna Mayhew Dr Michelle Eagle Emerita Professor Katherine Bushby	Detecting meaningful change using the North Star Ambulatory Assessment in Duchenne muscular dystrophy	2013
Dr Anna Mayhew Dr Michelle Eagle Meredith James Emerita Professor Katherine Bushby	Performance of Upper Limb Scale for use in Duchenne muscular dystrophy - An iterative process to establish its suitability for clinical trials	2013
Dr Tracey Willis Dr Kieren Hollingsworth Dr Michelle Eagle Dr Anna Mayhew Emerita Professor Katherine Bushby et al.	Quantitative Muscle MRI as an Assessment Tool for Monitoring Disease Progression in LGMD2I: A Multicentre Longitudinal Study	2013
Meredith James Dr Michelle Eagle Dr Anna Mayhew	Clinical Evaluator training for the GSK DEMAND programme	2012
Dr Michelle Eagle Dr Anna Mayhew Dr Eugen-Matthias Strehle	Development of a Functional Assessment Scale for Ambulatory Boys with Duchenne Muscular Dystrophy	2012
Dr Michelle Eagle Dr Anna Mayhew	Development of an upper limb functional scale in dystrophinopathies	2012
Dr Anna Mayhew Dr Michelle Eagle	Exploratory Rasch analysis of the EK2 scale used in a population of Duchenne muscular dystrophy (DMD)	2012
Dr Anna Mayhew Dr Michelle Eagle Emerita Professor Katherine Bushby	Trial readiness: Clinical interpretability of change scores of the North Star Ambulatory Assessment in Duchenne muscular dystropy	2012
Dr Tracey Willis Dr Kieren Hollingsworth Dr Michelle Eagle Dr Anna Mayhew Emerita Professor Katherine Bushby et al.	Assessing muscle pathology by MRI in LGMD2I	2011
Dr Anna Mayhew Dr Michelle Eagle Dr Tracey Willis Professor Volker Straub	Exploratory Rasch analysis of adapted North Star ambulatory assessment in LGMD 2I	2011
Dr Anna Mayhew Dr Michelle Eagle Emerita Professor Katherine Bushby Professor Volker Straub Dr Anna Sarkozy et al.	Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy	2011
Dr Tracey Willis Dr Kieren Hollingsworth Dr Michelle Eagle Dr Anna Mayhew Emerita Professor Katherine Bushby et al.	Quantitative MRI in LGMD2I; a longitudinal study	2011
Dr Michelle Eagle Dr Anna Mayhew Dr Tracey Willis Professor Hanns Lochmuller Emerita Professor Katherine Bushby et al.	Functional outcome measures in limb girdle muscular dystrophy 21: Correlations with MRI	2010